BioCentury | Jul 13, 2017
Clinical News

Neurotech's NT-501 meets in Phase II for macular telangiectasia

...end. NT-501 consists of encapsulated human cells genetically modified to secrete ciliary neurotrophic factor (CNTF). Neurotech Pharmaceuticals...
...BCVA) and reading speed Status: Phase II data Milestone: Start Phase III (year end 2017) Julian Zhu NT-501 Renexus Neurotech Pharmaceuticals...
BioCentury | Feb 18, 2016
Product R&D

Crossing paths

...cytokines Phase II Neuraltus Pharmaceuticals Inc. NP001 Small molecule regulator of macrophage activation Phase II Global Neurotech (GNT) Pharma Co. Ltd....
BioCentury | Jan 28, 2016
Distillery Therapeutics

Therapeutics: Microsomal prostaglandin E synthase-1 (PTGES; mPGES-1); prostaglandin E2 (PGE2)

...has LY3023703 , a PTGES inhibitor, in Phase II testing to treat osteoarthritis and pain. Global Neurotech (GNT) Pharma Co. Ltd....
BioCentury | Dec 3, 2015
Product R&D

Eyeing fewer needles

...transfect multiple cell types across a broad region of the retina cannot be turned off. Neurotech Pharmaceuticals...
...Co. Ltd. (Tokyo:4523), Tokyo, Japan Eyevensys S.A.S., Paris, France Genentech Inc., South San Francisco, Calif. Neurotech Pharmaceuticals...
...the eyes Company Compound Therapeutic modality Delivery route Proposed dosing schedule Description Lead indication Status Neurotech Pharmaceuticals...
BioCentury | Sep 7, 2015
Clinical News

NT-503 ECT: Phase II started

...who have been treated with >=3 anti-VEGF injections and have demonstrated a good clinical response. Neurotech Pharmaceuticals...
BioCentury | Apr 16, 2015
Company News

Management tracks

...Park, N.C.) hired Rhett Schiffman as CMO and SVP of development. Schiffman was CMO at Neurotech Pharmaceuticals...
BioCentury | Mar 20, 2015
Company News

Management tracks

...of NuPathe Inc. , which was acquired by Teva Pharmaceutical Industries Ltd. (NYSE:TEVA). Ophthalmic play Neurotech Pharmaceuticals...
BioCentury | Feb 3, 2014
Emerging Company Profile

ImStar: Neuronal pacifier

...with preclinical programs designed to target neuroinflammation associated with ALS include FPRT Bio Inc. ; Global Neurotech (GNT) Pharma Co. Ltd....
...enter the clinic in 2015. Companies and Institutions Mentioned FPRT Bio Inc. , Scranton, Pa. Global Neurotech (GNT) Pharma Co. Ltd....
BioCentury | Jan 20, 2014
Emerging Company Profile

Zocere: Stepping up in stroke

...JNK will act at different stages of an ischemic insult," said Zocere CEO Wayne Laslie. Global Neurotech (GNT) Pharma Co. Ltd....
...Institutions Mentioned Boehringer Ingelheim GmbH , Ingelheim, Germany Genentech Inc. , South San Francisco, Calif. Global Neurotech (GNT) Pharma Co. Ltd....
BioCentury | Mar 11, 2013
Emerging Company Profile

FPRT Bio: Neutralizing neuroinflammation

...C5b-9 membrane attack complex (MAC) in preclinical development for ALS, MS and myasthenia gravis. Additionally, Global Neurotech (GNT) Pharma Co. Ltd....
...Phase II in both indications. Companies and Institutions Mentioned FPRT Bio Inc. , Scranton, Pa. Global Neurotech (GNT) Pharma Co. Ltd....
Items per page:
1 - 10 of 26
BioCentury | Jul 13, 2017
Clinical News

Neurotech's NT-501 meets in Phase II for macular telangiectasia

...end. NT-501 consists of encapsulated human cells genetically modified to secrete ciliary neurotrophic factor (CNTF). Neurotech Pharmaceuticals...
...BCVA) and reading speed Status: Phase II data Milestone: Start Phase III (year end 2017) Julian Zhu NT-501 Renexus Neurotech Pharmaceuticals...
BioCentury | Feb 18, 2016
Product R&D

Crossing paths

...cytokines Phase II Neuraltus Pharmaceuticals Inc. NP001 Small molecule regulator of macrophage activation Phase II Global Neurotech (GNT) Pharma Co. Ltd....
BioCentury | Jan 28, 2016
Distillery Therapeutics

Therapeutics: Microsomal prostaglandin E synthase-1 (PTGES; mPGES-1); prostaglandin E2 (PGE2)

...has LY3023703 , a PTGES inhibitor, in Phase II testing to treat osteoarthritis and pain. Global Neurotech (GNT) Pharma Co. Ltd....
BioCentury | Dec 3, 2015
Product R&D

Eyeing fewer needles

...transfect multiple cell types across a broad region of the retina cannot be turned off. Neurotech Pharmaceuticals...
...Co. Ltd. (Tokyo:4523), Tokyo, Japan Eyevensys S.A.S., Paris, France Genentech Inc., South San Francisco, Calif. Neurotech Pharmaceuticals...
...the eyes Company Compound Therapeutic modality Delivery route Proposed dosing schedule Description Lead indication Status Neurotech Pharmaceuticals...
BioCentury | Sep 7, 2015
Clinical News

NT-503 ECT: Phase II started

...who have been treated with >=3 anti-VEGF injections and have demonstrated a good clinical response. Neurotech Pharmaceuticals...
BioCentury | Apr 16, 2015
Company News

Management tracks

...Park, N.C.) hired Rhett Schiffman as CMO and SVP of development. Schiffman was CMO at Neurotech Pharmaceuticals...
BioCentury | Mar 20, 2015
Company News

Management tracks

...of NuPathe Inc. , which was acquired by Teva Pharmaceutical Industries Ltd. (NYSE:TEVA). Ophthalmic play Neurotech Pharmaceuticals...
BioCentury | Feb 3, 2014
Emerging Company Profile

ImStar: Neuronal pacifier

...with preclinical programs designed to target neuroinflammation associated with ALS include FPRT Bio Inc. ; Global Neurotech (GNT) Pharma Co. Ltd....
...enter the clinic in 2015. Companies and Institutions Mentioned FPRT Bio Inc. , Scranton, Pa. Global Neurotech (GNT) Pharma Co. Ltd....
BioCentury | Jan 20, 2014
Emerging Company Profile

Zocere: Stepping up in stroke

...JNK will act at different stages of an ischemic insult," said Zocere CEO Wayne Laslie. Global Neurotech (GNT) Pharma Co. Ltd....
...Institutions Mentioned Boehringer Ingelheim GmbH , Ingelheim, Germany Genentech Inc. , South San Francisco, Calif. Global Neurotech (GNT) Pharma Co. Ltd....
BioCentury | Mar 11, 2013
Emerging Company Profile

FPRT Bio: Neutralizing neuroinflammation

...C5b-9 membrane attack complex (MAC) in preclinical development for ALS, MS and myasthenia gravis. Additionally, Global Neurotech (GNT) Pharma Co. Ltd....
...Phase II in both indications. Companies and Institutions Mentioned FPRT Bio Inc. , Scranton, Pa. Global Neurotech (GNT) Pharma Co. Ltd....
Items per page:
1 - 10 of 26